Blackout Redaction Now Live on Reveal Enterprise Platform
The full deployment to interested Reveal Enterprise customers follows the company's strategic acquisition of the Blackout source code late last year. The result is a seamless, intelligent redaction experience—dramatically improving the speed, accuracy, and efficiency of sensitive data protection during legal review.
'By bringing Blackout into the Reveal ecosystem, we're giving legal teams more choice and control in how they manage redactions at scale,' said Wendell Jisa, Founder & CEO of Reveal. 'It's a powerful tool that the industry is familiar with and eliminates bottlenecks, reduces risk, and enhances outcomes across the discovery process.'
With Blackout now available on the Reveal Enterprise platform, customers can natively redact personally identifiable information, privileged content, and other sensitive materials in spreadsheets with precision—while maintaining full control over review workflows. This builds on Reveal's already robust set of fully integrated image-based redaction capabilities, which are available globally through its strategic partners. Trusted across the legal industry with over six billion redactions placed to date, Blackout further strengthens Reveal's commitment to delivering practical, scalable, and secure solutions for modern legal teams.
Reveal Enterprise customers can access Blackout today at no additional cost. Global rollout will continue through 2025, including a Q1 launch on Reveal's Logikcull platform Q1 2026.
Reveal is transforming the legal industry with a scalable AI-powered ecosystem built on two industry-leading platforms. Reveal Enterprise offers end-to-end solutions—from data governance to trial presentation—designed for the most complex legal needs, while Reveal's Logikcull platform delivers self-service eDiscovery for firms of all sizes. Together, they empower legal teams across Fortune 500 companies, law firms, and government agencies to streamline discovery with speed, precision, and confidence. Learn more at www.revealdata.com.
About Reveal
Reveal is a leading AI-powered platform for eDiscovery, document review, legal hold and investigations. The company has a deep history in driving the adoption of legal automation, which is underpinned by its leading processing technology, visual analytics, and artificial intelligence capabilities. Reveal's software combines technology and human guidance to transform structured and unstructured data into actionable insight. We help organizations, including law firms, corporations, government agencies, and intelligence services, uncover more useful information faster by providing a world-class user experience and AI technology that is embedded within every phase of the eDiscovery process.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 hours ago
- Business Wire
Haleon Breaks Ground on new £130m Global Oral Health Innovation Centre
LONDON--(BUSINESS WIRE)--This week, Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke ground on its new Global Oral Health Innovation Centre in Weybridge, Surrey. This state-of-the-art facility will enhance Haleon's science capabilities, accelerate innovation, and serve as a centre of excellence for global oral health research. The groundbreaking ceremony, attended by UK Minister Baroness Jones, marks an important step in Haleon's ambition to reach one billion more consumers by 2030, by strengthening its oral health R&D capabilities to put health in more hands globally. Set to become the R&D epicentre for Haleon's oral health portfolio, the centre will be a dynamic hub for pioneering research, product innovation, commercial and supply chain excellence, and cross-functional collaboration. Equipped with the latest technology and global expertise, the centre will feature a cutting-edge digital immersive room designed to unlock value at pace through real-time collaboration with Haleon's manufacturing site in Levice. At the heart of the building, the atrium will create a vibrant hub for teamwork and co-creation, bringing leading expertise together to develop solutions that address unmet oral health needs for consumers around the world. Designed with sustainability at its core, the site has recently achieved a BREEAM® Outstanding rating, recognising its exceptional commitment to sustainability at Phase 1 in the design stage. Franck Riot, Chief R&D Officer, Haleon, said:" We are excited to break ground on our Global Oral Health Innovation Centre - a major investment reflecting our commitment to advancing science and innovation. This powerhouse for oral health research will strengthen Haleon's R&D capabilities and accelerate the development of cutting-edge solutions to meet the evolving oral health needs of consumers around the world. ' Chancellor of the Exchequer, Rachel Reeves MP, said: 'This exciting milestone is another demonstration of the strength of the UK life sciences sector, a key pillar to our Industrial Strategy. Under this government Britain is open for business, and through our Plan for Change we're delivering more investment, more jobs and more money in people's pockets.' UK Minister for Technology, Baroness Jones, said: 'Haleon is breaking ground on a new centre that will place the UK at the forefront of innovation to improve everyone's oral health - which we know is important to our wider health, and to children's development. This centre, and the substantial investment behind it, is proof that the UK's world-leading life sciences sector is the place to be to grow businesses and work on fresh ideas to transform healthcare. Leveraging these strengths will lead to the long-term economic growth that will help us deliver on our Plan for Change.' Jayant Singh, Global Category Lead, Oral Health, Haleon, said:" With oral diseases affecting nearly half the world's population, this marks an exciting step forward in our mission to put health in more hands for millions across the world. This centre will play a key role in harnessing the full potential of science and innovation across our oral health portfolio. ' About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
Business Wire
7 hours ago
- Business Wire
Form 8.3 - Life Science REIT plc
BOSTON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the 'Code') 1. KEY INFORMATION (a) Full name of discloser: Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Life Science REIT plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 3 July 2025 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state 'N/A' N/A Expand 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 1p ordinary – 350,000,000 (ISIN: GB00BP5X4Q29) Interests Short Positions Number % Number % (1) Relevant securities owned and/or controlled: (2) Cash-settled derivatives: 5,080,638 1.45 (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 5,080,638 1.45 Expand All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors' and other employee options) Class of relevant security in relation to which subscription right exists: N/A Details, including nature of the rights concerned and relevant percentages: N/A Expand 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/Sale Number of securities Price per unit N/A N/A N/A N/A Expand (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. Opening/Closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit 1p ordinary CFD Increasing a long position 100,000 GBP 0.4400 1p ordinary CFD Increasing a long position 8,111 GBP 0.4390 Expand (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit N/A N/A N/A N/A N/A N/A N/A N/A Expand (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit N/A N/A N/A N/A N/A Expand (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) N/A N/A N/A N/A Expand 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state 'none' None Expand (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state 'none' None Expand (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? No Expand Date of disclosure: 4 July 2025 Contact name: Mary Merrigan Telephone number: +1 617 778 7775 Expand Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at
Business Wire
8 hours ago
- Business Wire
QISITECH Redefines Exhibition Norms at the World Vape Show: A Live Showcase of Automated ODM Mastery
DUBAI, United Arab Emirates--(BUSINESS WIRE)--At the World Vape Show in Dubai (June 18–20, 2025), QISITECH's Geek Design team made a powerful statement by unveiling the industry's first live demonstration of a fully automated vape production line. This groundbreaking showcase highlighted the company's all-in-one ODM model—combining product development, branding, manufacturing, and marketing—with a strong focus on automation, precision, and speed-to-market. Powered by QISI Intelligent Manufacturing, the production line reflected the brand's design-for-manufacturing (DFM) and design-for-automation (DFA) principles. The system featured modular robotics, AI-driven vision systems, real-time quality control, and three automated stages: e-liquid cup assembly, finished product assembly, and packaging. The four machines on display were part of a complete automation ecosystem designed for scalable, high-efficiency output. QISITECH's ODM framework hinges on four core pillars: Product: Rigorous DFM (Design for Manufacturing) and DFA (Design for Automation) assessments ensure designs are production-ready from conception. Branding: Crafting distinct identities for products supported by global compliance (700+ certifications including TPD). Production: Leveraging QISI's 220,000 m² smart manufacturing campus, outfitted with 16 core-tech patents for modular production lines. Marketing: End-to-end support from POS materials to consumer engagement campaigns. The booth also featured popular products like the award-winning RAZ Series, Powered by Raz RYL, KRAZE, and bracelet-style KRAZE LUNA, as well as the high-performance i:FORCE line—showcasing QISITECH's broad development capabilities. What set this showcase apart was its transparency and interactivity. Visitors witnessed every production stage live, gaining insight into how real-time automation and integrated design can transform concepts into retail-ready products efficiently and reliably. QISITECH's strength lies in its 'three-in-one' model—smart manufacturing, digital control, and automation—supported by an agile supply chain that handles both pilot runs and large-scale production. Its rigorous quality systems (PQ, NPI, PE, SQ) and in-house process control ensure high yields with minimal deviation. With an independent R&D institute and design-driven culture, QISITECH continues to accelerate innovation. Future plans include expanded AI automation, age-verification tech, and a stronger end-to-end ODM offering. QISITECH's Dubai showcase re-imagined the trade show paradigm by bringing manufacturing to the forefront. By demonstrating how design, technology, and branding converge in real-time, the brand solidified its role as a leader in automated ODM, proving that innovation thrives where transparency and engineering excellence coexist.
